Literature DB >> 30107265

The link between immunity, autoimmunity and endometriosis: a literature update.

Tao Zhang1, Caterina De Carolis2, Gene Chi Wai Man3, Chi Chiu Wang4.   

Abstract

Endometriosis (EMS), an estrogen-dependent inflammatory disorder affects approximately 5-10% of the general female population of reproductive age and 20-90% of women with pelvic pain and infertility. Many immunological factors are known to contribute significantly to the pathogenesis and pathophysiology of EMS, and both chronic local inflammation and autoantibodies in EMS shares many similarities with autoimmune diseases (AD). However, the autoimmune etiology in EMS remains controversial, and its evidence on autoimmune basis may be limited. Here we aim to review the current understanding between autoimmunity and EMS to provide important knowledge to develop future potential immunomodulatory therapy for the treatment of EMS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmune disease (AD); Complement (C); Cytokines; Endometriosis (EMS); Immune escape; Immunomodulators

Mesh:

Substances:

Year:  2018        PMID: 30107265     DOI: 10.1016/j.autrev.2018.03.017

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  41 in total

Review 1.  Environmental Endocrine Disruptors and Endometriosis.

Authors:  Jelonia T Rumph; Victoria R Stephens; Anthony E Archibong; Kevin G Osteen; Kaylon L Bruner-Tran
Journal:  Adv Anat Embryol Cell Biol       Date:  2020       Impact factor: 1.231

Review 2.  Endometriosis and Systemic Lupus Erythematosus: Systematic Review and Meta-analysis.

Authors:  João Pedro Ferrari-Souza; Mirela Tschiedel Pedrotti; Enrico Emerim Moretto; Laura Penso Farenzena; Luís Guilherme Crippa; João Sabino Cunha-Filho
Journal:  Reprod Sci       Date:  2022-08-01       Impact factor: 2.924

Review 3.  Pentoxifylline for the treatment of endometriosis-associated pain and infertility.

Authors:  Alexandros Loukas Grammatis; Ektoras X Georgiou; Christian M Becker
Journal:  Cochrane Database Syst Rev       Date:  2021-08-25

4.  Inflammation-mediated macrophage polarization induces TRPV1/TRPA1 heteromers in endometriosis.

Authors:  Hai Zhu; Yi Wang; Yibo He; Weifeng Yu
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 5.  The Role of the Immune System in the Development of Endometriosis.

Authors:  Monika Abramiuk; Ewelina Grywalska; Paulina Małkowska; Olga Sierawska; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

6.  Risk of systemic lupus erythematosus in patients with endometriosis: A nationwide population-based cohort study.

Authors:  Ya-Hui Lin; Yu-Cih Yang; Shih-Fen Chen; Chung-Y Hsu; Yu-Chih Shen
Journal:  Arch Gynecol Obstet       Date:  2020-08-06       Impact factor: 2.344

7.  Anesthetic Bladder Capacity is a Clinical Biomarker for Interstitial Cystitis/Bladder Pain Syndrome Subtypes.

Authors:  Andre Plair; Robert J Evans; Carl D Langefeld; Catherine A Matthews; Gopal Badlani; Stephen J Walker
Journal:  Urology       Date:  2021-07-22       Impact factor: 2.649

8.  Network Pharmacology-Based Prediction of Bioactive Compounds and Potential Targets of Wenjing Decoction for Treatment of Endometriosis.

Authors:  Yu-Nan Liu; Xiao-Jing Hu; Bei Liu; Yu-Jie Shang; Wen-Ting Xu; Hui-Fang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-24       Impact factor: 2.629

9.  Toll-Like Receptor 2 Expression as a New Hallmark of Advanced Endometriosis.

Authors:  Małgorzata Sobstyl; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska; Izabela Korona-Głowniak; Anna Sobstyl; Wiesława Bednarek; Jacek Roliński
Journal:  Cells       Date:  2020-07-30       Impact factor: 6.600

Review 10.  Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases.

Authors:  Ning Huang; Hongbin Chi; Jie Qiao
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.